These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1802987)

  • 1. Thrombolytic effect of tissue plasminogen activator in a cerebral embolic model.
    Kimata H; Nakajima K; Suzuki H; Koide T; Narita T
    J Pharmacobiodyn; 1991 Jul; 14(7):399-406. PubMed ID: 1802987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic effect of tissue plasminogen activator on cerebral embolism in stroke-prone spontaneously hypertensive rats.
    Kimata H; Nakajima K; Suzuki H; Koide T; Yamamoto S; Narita T
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3327-30. PubMed ID: 1814626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061).
    Hara T; Iwamoto M; Ogawa H; Yamamoto A; Tomikawa M
    Thromb Res; 1990 Aug; 59(4):703-12. PubMed ID: 2127865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis.
    Schneider J; Friderichs E; Günzler WA; Flohé L
    Thromb Res; 1989 Oct; 56(1):59-65. PubMed ID: 2512686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of tissue plasminogen activator on experimental microthrombi in rats. Microautoradiographic observations.
    Kimata H; Koide T; Nakajima K; Kondo S
    J Pharmacobiodyn; 1991 Jan; 14(1):25-33. PubMed ID: 1907322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of tissue plasminogen activator on experimental thrombi in rats.
    Kimata H; Nakajima K; Koide T; Yamamoto S; Kondo S
    J Pharmacobiodyn; 1990 Dec; 13(12):751-9. PubMed ID: 2129128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.
    Penar PL; Greer CA
    Yale J Biol Med; 1987; 60(3):233-43. PubMed ID: 3111108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.
    Badylak SF; Voytik S; Klabunde RE; Henkin J; Leski M
    Thromb Res; 1988 Nov; 52(4):295-312. PubMed ID: 3144052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
    Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of human tissue plasminogen activator (t-PA) to blood clots and clot-lytic activity of clot-bound t-PA.
    Kimata H; Nakajima K; Yamamoto S; Hasegawa A
    J Pharmacobiodyn; 1990 Dec; 13(12):745-50. PubMed ID: 2129127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.
    Sakurama T; Kitamura R; Kaneko M
    Stroke; 1994 Feb; 25(2):451-6. PubMed ID: 8303756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic efficacy of a modified tissue-type plasminogen activator, SUN9216, in the rat middle cerebral artery thrombosis model.
    Umemura K; Toshima Y; Nakashima M
    Eur J Pharmacol; 1994 Sep; 262(1-2):27-31. PubMed ID: 7813575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.